# RA Denosumab on Bone Microstructure Study

> **NCT01770106** · PHASE4 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 40 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Denosumab
- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT01770106
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-09-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01770106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01770106, "RA Denosumab on Bone Microstructure Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01770106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*